Ali Moshfegh

1.9k total citations
60 papers, 1.4k citations indexed

About

Ali Moshfegh is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Ali Moshfegh has authored 60 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 20 papers in Immunology and 17 papers in Oncology. Recurrent topics in Ali Moshfegh's work include Chronic Lymphocytic Leukemia Research (12 papers), PI3K/AKT/mTOR signaling in cancer (9 papers) and Wnt/β-catenin signaling in development and cancer (9 papers). Ali Moshfegh is often cited by papers focused on Chronic Lymphocytic Leukemia Research (12 papers), PI3K/AKT/mTOR signaling in cancer (9 papers) and Wnt/β-catenin signaling in development and cancer (9 papers). Ali Moshfegh collaborates with scholars based in Sweden, Iran and Greece. Ali Moshfegh's co-authors include Håkan Mellstedt, Vladimir J.N. Bykov, Klas G. Wiman, Joachim Lundahl, Mohammad Hojjat‐Farsangi, Anders Österborg, Amir Hossein Daneshmanesh, Sören Lehmann, Dina Ali and Ove Andrén and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Ali Moshfegh

60 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Moshfegh Sweden 21 755 524 304 226 178 60 1.4k
Antônio Palumbo Brazil 21 676 0.9× 277 0.5× 265 0.9× 285 1.3× 133 0.7× 47 1.4k
David E. Muench United States 14 812 1.1× 279 0.5× 359 1.2× 331 1.5× 199 1.1× 22 1.4k
Patrick Chu United Kingdom 14 756 1.0× 768 1.5× 156 0.5× 374 1.7× 151 0.8× 32 1.6k
George Sigounas United States 20 668 0.9× 350 0.7× 172 0.6× 233 1.0× 220 1.2× 41 1.5k
Monika Podhorecka Poland 14 600 0.8× 333 0.6× 234 0.8× 166 0.7× 98 0.6× 51 1.2k
Eleonora Petrucci Italy 22 856 1.1× 358 0.7× 255 0.8× 387 1.7× 264 1.5× 35 1.6k
Jia Song China 22 652 0.9× 198 0.4× 295 1.0× 317 1.4× 307 1.7× 119 1.4k
Wei Sheng China 20 484 0.6× 522 1.0× 614 2.0× 129 0.6× 293 1.6× 72 1.6k
Erika Rimondi Italy 20 830 1.1× 356 0.7× 310 1.0× 269 1.2× 65 0.4× 65 1.3k
Ling Xue China 26 797 1.1× 604 1.2× 385 1.3× 273 1.2× 85 0.5× 79 2.0k

Countries citing papers authored by Ali Moshfegh

Since Specialization
Citations

This map shows the geographic impact of Ali Moshfegh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Moshfegh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Moshfegh more than expected).

Fields of papers citing papers by Ali Moshfegh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Moshfegh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Moshfegh. The network helps show where Ali Moshfegh may publish in the future.

Co-authorship network of co-authors of Ali Moshfegh

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Moshfegh. A scholar is included among the top collaborators of Ali Moshfegh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Moshfegh. Ali Moshfegh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kokhaei, Parviz, Ali Moshfegh, Jeanette Lundin, et al.. (2024). A Small Molecule Antagonist of CX3CR1 (KAND567) Inhibited the Tumor Growth-Promoting Effect of Monocytes in Chronic Lymphocytic Leukemia (CLL). Cancers. 16(22). 3821–3821. 3 indexed citations
2.
Hojjat‐Farsangi, Mohammad, Amir Hossein Daneshmanesh, Fariba Mozaffari, et al.. (2017). First-in-Class Oral Small Molecule Against the Tyrosine Kinase ROR1 (KAN0439834) Induced Significant Apoptosis of Chronic Lymphocytic Leukemia Cells. Blood. 130. 4320–4320. 1 indexed citations
3.
Bentinger, Magnus, Octavian Savu, Ali Moshfegh, et al.. (2016). Mono-epoxy-tocotrienol-α enhances wound healing in diabetic mice and stimulates in vitro angiogenesis and cell migration. Journal of Diabetes and its Complications. 31(1). 4–12. 23 indexed citations
4.
Mellstedt, Håkan, Mohammad Hojjat‐Farsangi, Amir Hossein Daneshmanesh, et al.. (2016). First generation of a small chemical molecule ROR1 RTK tyrosine kinase inhibitor. Annals of Oncology. 27. vi530–vi530. 3 indexed citations
5.
Jaing, Crystal, James B. Thissen, Shea N. Gardner, et al.. (2016). Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions. Oncology Letters. 12(4). 2782–2788. 6 indexed citations
6.
Khan, Abdul Salam, Mohammad Hojjat‐Farsangi, Amir Hossein Daneshmanesh, et al.. (2016). Dishevelled proteins are significantly upregulated in chronic lymphocytic leukaemia. Tumor Biology. 37(9). 11947–11957. 26 indexed citations
7.
Hojjat‐Farsangi, Mohammad, Mahmood Jeddi‐Tehrani, Amir Hossein Daneshmanesh, et al.. (2015). Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia. PLoS ONE. 10(11). e0142310–e0142310. 13 indexed citations
8.
El‐Serafi, Ibrahim, Mohammad M. Fares, Manuchehr Abedi‐Valugerdi, et al.. (2015). Cytochrome P450 2J2, a new key enzyme in cyclophosphamide bioactivation and a potential biomarker for hematological malignancies. The Pharmacogenomics Journal. 15(5). 405–413. 24 indexed citations
9.
Ståhl, Sara, Vitaliy O. Kaminskyy, Alena Hyršlová Vaculová, et al.. (2013). Inhibition of Ephrin B3-mediated survival signaling contributes to increased cell death response of non-small cell lung carcinoma cells after combined treatment with ionizing radiation and PKC 412. Cell Death and Disease. 4(1). e454–e454. 21 indexed citations
10.
Moshfegh, Ali, et al.. (2013). Activation of Wnt/β-Catenin Pathway in Monocytes Derived from Chronic Kidney Disease Patients. PLoS ONE. 8(7). e68937–e68937. 21 indexed citations
11.
Sadeghi, Behnam, Manuchehr Abedi‐Valugerdi, Raoul Kuiper, et al.. (2013). The Role of Programmed Cell Death Ligand-1 (PD-L1/CD274) in the Development of Graft versus Host Disease. PLoS ONE. 8(4). e60367–e60367. 13 indexed citations
12.
Bahnassy, Abeer A., Anders Österborg, Katja Pokrovskaja Tamm, et al.. (2012). Patients with activated B-cell like diffuse large B-cell lymphoma in high and low infectious disease areas have different inflammatory gene signatures. Leukemia & lymphoma. 54(5). 996–1003. 7 indexed citations
13.
Hashemi, Jamileh, et al.. (2011). The pattern of gene expression and gene dose profiles of 6-Mercaptopurine- and 6-Thioguanine-resistant human leukemia cells. Biochemical and Biophysical Research Communications. 411(1). 156–161. 13 indexed citations
14.
Olsson, Jenny, et al.. (2010). Expression of neutrophil SOD2 is reduced after lipopolysaccharide stimulation: a potential cause of neutrophil dysfunction in chronic kidney disease. Nephrology Dialysis Transplantation. 26(7). 2195–2201. 26 indexed citations
15.
Lambert, Jérémy, Ali Moshfegh, Pierre Hainaut, Klas G. Wiman, & Vladimir J.N. Bykov. (2009). Mutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosis. Oncogene. 29(9). 1329–1338. 85 indexed citations
16.
Olsson, Jenny, et al.. (2007). Preserved leukocyte CD11b expression at the site of interstitial inflammation in patients with high-flux hemodiafiltration. Kidney International. 71(6). 582–588. 5 indexed citations
17.
Moshfegh, Ali, et al.. (2007). The stress of birth enhances in vitro spontaneous and IL‐8‐induced neutrophil chemotaxis in the human newborn. Pediatric Allergy and Immunology. 18(8). 643–651. 73 indexed citations
18.
Kokhaei, Parviz, A Choudhury, Reza Mahdian, et al.. (2004). Apoptotic tumor cells are superior to tumor cell lysate, and tumor cell RNA in induction of autologous T cell response in B-CLL. Leukemia. 18(11). 1810–1815. 60 indexed citations
19.
Moshfegh, Ali, et al.. (2002). Impact of Hemodialysis Membrane and Permeability on Neutrophil Transmigration in vitro. ˜The œNephron journals/Nephron journals. 91(4). 659–665. 8 indexed citations
20.
Brauner, Annelie, Britta Hylander, Stefan H. Jacobson, Ali Moshfegh, & Joachim Lundahl. (2001). Increased Expression of CD25 and HLA-DR on Lymphocytes Recruited into the Peritoneal Cavity in Non-Infected CAPD Patients. Inflammation. 25(6). 399–404. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026